[S-31] シンポジウム31

[S-31-4] パーキンソン病および非定型パーキンソン症候群の病態イメージング -疾患修飾薬の実現へ向けて-

島田 斉^1,2,3 (1.新潟大学脳研究所 統合脳機能研究センター 臨床機能脳神経学分野, 2.量子科学技術研究開発機構 量子医科学研究所 脳機能イメージング研究部, 3.千葉大学大学院医学研究院 脳神経内科学)

Dr. Shimada obtained his M.D. from Chiba University in 2003 and trained in Neurology at Chiba University Hospital and affiliated hospitals. He received his Ph.D. degree in Advanced Life Science from Chiba University, Japan, in 2009. He was a postdoctoral researcher from April 2009, a researcher from December 2009, senior researcher from July 2014, and the principal researcher from July 2017 at the Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology (QST), Chiba, Japan. He has transferred to the Center for integrated human brain science of Niigata University as a professor as of April 1st, 2021. His current research interests include Molecular Neuroimaging (especially neuropathological imaging such as amyloid, tau, and synuclein PET imaging) in Neurodegenerative disorders, physiological background of psychiatric symptoms, human perception and cognition, and neuroplasticity.